(Q45762731)

15 December 2017

title

Determinants and kinetics of cytokine expression patterns in lungs of vaccinated mice challenged with respiratory syncytial virus (English)

1 reference

15 December 2017

6

Graham BS

1 reference

15 December 2017

Kathleen Neuzil

2

object named as

Neuzil KM

1 reference

15 December 2017

author name string

Tang YW

1

1 reference

15 December 2017

Fischer JE

3

1 reference

15 December 2017

Robinson FW

4

1 reference

15 December 2017

Parker RA

5

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 April 1997

1 reference

15 December 2017

published in

Vaccine

1 reference

15 December 2017

volume

15

1 reference

15 December 2017

page(s)

597-602

1 reference

15 December 2017

issue

6-7

1 reference

15 December 2017

Prospects for a respiratory syncytial virus vaccine

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900214-9

7 January 2021

Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900214-9

7 January 2021

Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900214-9

7 January 2021

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900214-9

7 January 2021

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900214-9

7 January 2021

Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900214-9

7 January 2021

Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900214-9

7 January 2021

Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900214-9

7 January 2021

Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900214-9

7 January 2021

Susceptibility to Leishmania major infection in interleukin-4-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900214-9

7 January 2021

Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900214-9

7 January 2021

Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900214-9

7 January 2021

Distinct types of lung disease caused by functional subsets of antiviral T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900214-9

7 January 2021

Immunological determinants of disease caused by respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900214-9

7 January 2021

Primary respiratory syncytial virus infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900214-9

7 January 2021

Reinfection of mice with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900214-9

7 January 2021

Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900214-9

7 January 2021

Cytokine-specific ELISPOT assay. Single cell analysis of IL-2, IL-4 and IL-6 producing cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900214-9

7 January 2021

Switch of CD8 T cells to noncytolytic CD8-CD4- cells that make TH2 cytokines and help B cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900214-9

7 January 2021

Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900214-9

7 January 2021

Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900214-9

7 January 2021

T cell and non-T cell compartments can independently determine resistance to Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900214-9

7 January 2021

10.1016/S0264-410X(96)00214-9

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

9178456

1 reference

15 December 2017